ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Astellas licences Frequency Therapeutics’ hearing loss drug
July 19, 2019Astellas Pharma has signed an exclusive licensing agreement to develop and commercialise Frequency Therapeutics’ drug candidate FX-322 for sensorineural hearing loss. -
Licences for manufacturers and wholesalers of medicines and ingredients
December 13, 2018Updated public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended…
Pharma Sources Insight January 2025
